Compare IMNM & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | BANC |
|---|---|---|
| Founded | 2006 | 1941 |
| Country | United States | United States |
| Employees | N/A | 1904 |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2020 | N/A |
| Metric | IMNM | BANC |
|---|---|---|
| Price | $22.12 | $21.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $32.80 | $21.83 |
| AVG Volume (30 Days) | 1.7M | ★ 2.7M |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | N/A | $13.93 |
| Revenue Next Year | $1,127.34 | $8.03 |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.67 | $13.96 |
| 52 Week High | $27.65 | $21.61 |
| Indicator | IMNM | BANC |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 62.44 |
| Support Level | $19.28 | $19.40 |
| Resistance Level | $23.25 | $21.43 |
| Average True Range (ATR) | 1.36 | 0.42 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 45.98 | 76.51 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.